Product image of Lansoprazol Krka (Lansoprazole) supplied by GNH India

Lansoprazol Krka

Active Ingredient:
Lansoprazole
Origin:
EU

Lansoprazol Krka (Lansoprazole)

Lansoprazole, the active ingredient in Lansoprazol Krka, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed in the management of acid‑related gastrointestinal conditions such as reflux disease and ulcers.

GNH India supplies Lansoprazol Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures product quality through rigorous testing and adheres to global regulatory standards for safe distribution across all markets.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lansoprazole is used to treat acid‑related disorders by decreasing gastric acid secretion.

  • Gastroesophageal reflux disease (GERD): reduces acid exposure, relieving heartburn and regurgitation.
  • Erosive esophagitis: promotes healing of inflamed esophageal lining.
  • Peptic ulcer disease: facilitates ulcer healing and prevents recurrence.
  • Helicobacter pylori eradication regimens: enhances effectiveness of antibiotic therapy by suppressing acid.

How It Works

  • Lansoprazole selectively and irreversibly binds to the H⁺/K⁺‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly lowers both basal and stimulated gastric acidity, providing prolonged suppression of gastric secretions. The inhibition is sustained for up to 72 hours because the drug covalently modifies the pump, and new enzyme synthesis is required for acid secretion to resume.

Side Effects

Lansoprazole may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Headache: mild headache reported in clinical use.
  • Diarrhea: loose stools occurring during therapy.
  • Nausea: transient feeling of queasiness.
  • Abdominal pain: mild stomach discomfort.
  • Flatulence: increased intestinal gas.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Clostridioides difficile infection: persistent diarrhea with abdominal pain.
  • Low magnesium levels: muscle cramps, irregular heartbeat.
  • Bone fractures: increased risk with long‑term use.
  • Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Precautions & Warnings

Before initiating Lansoprazole therapy, consider the following precautions to ensure safe use.

  • Assess renal function: dose adjustment may be needed in severe impairment.
  • Evaluate hepatic status: monitor for accumulation in liver disease.
  • Review concomitant medications: potential interactions may require monitoring.
  • Use the lowest effective dose: limit duration to the shortest period necessary.
  • Pregnancy and lactation: discuss risks with a healthcare professional.
  • Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Lansoprazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid)

  • Antifungal azoles (ketoconazole, itraconazole): reduced absorption and efficacy.
  • HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma levels.
  • Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible increase in INR, monitor coagulation.
  • Digoxin: higher serum concentrations may occur.
  • Methotrexate: reduced renal clearance, monitor for toxicity.
  • Mycophenolate mofetil: decreased exposure, adjust dose if needed.

Frequently Asked Questions

Lansoprazol Krka, containing the active ingredient lansoprazole, is indicated for the management of acid‑related gastrointestinal disorders. It is commonly prescribed for gastroesophageal reflux disease (GERD), erosive esophagitis, peptic ulcer disease, and as part of combination therapy for Helicobacter pylori eradication.

Lansoprazole belongs to the proton pump inhibitor class. It binds irreversibly to the H⁺/K⁺‑ATPase enzyme (the gastric proton pump) on parietal cells, blocking the final step of acid secretion. This results in a sustained decrease in both basal and stimulated gastric acidity.

The appropriate dose of Lansoprazol Krka is determined by the prescribing clinician based on the specific indication, severity of disease, patient age, renal and hepatic function, and any concomitant therapies. Dosage regimens are individualized and should follow the prescriber’s written instructions.

Safety data for lansoprazole in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus. Women who are breastfeeding should consult their healthcare provider, as the medication may be excreted in breast milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Lansoprazol Krka. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lansoprazole and omeprazole are both proton pump inhibitors and share a similar mechanism of action. Clinical studies suggest comparable efficacy in healing erosive esophagitis and ulcer disease, though individual patient response, drug‑interaction profiles, and tolerability may differ. Choice of agent often depends on physician preference and patient-specific factors.

Lansoprazol Krka should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat, and direct sunlight to maintain stability and potency throughout its shelf life.

Lansoprazol Krka is taken orally, usually as a tablet or capsule, with a glass of water. It is generally recommended to swallow the dosage form whole, preferably before a meal, unless the prescribing information advises otherwise.

Serious but rare risks include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhea, low magnesium levels leading to cardiac arrhythmias, acute interstitial nephritis, and an increased risk of bone fractures with long‑term use. Patients should seek immediate medical attention if they experience any of these symptoms.

Lansoprazol Krka should be avoided in individuals with known hypersensitivity to lansoprazole or other proton pump inhibitors. Caution is also advised for patients with severe liver disease, those taking medications that require an acidic environment for absorption, and patients with a history of certain infections such as C. difficile.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lansoprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT